Pascal Touchon, President and CEO at Atara Biotherapeutics, Inc. (ATRA), sold 28,388 shares at $16.32 ($463K) on 2021-06-25, disclosed to the SEC on 2021-06-29.
Open-market sale of $463k ATRA by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.32 | 14,194 | $232K | 50.0% |
| 2 | $16.32 | 14,194 | $232K | 50.0% |
| Total | $16.32 avg | 28,388 | $463K | 100% |
| Filing → |
| ATRA | SELL | 2024-03-06 | $18K | — | Filing → |
| ATRA | SELL | 2023-11-20 | $8K | — | Filing → |
| ATRA | SELL | 2023-08-18 | $51K | — | Filing → |